Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

Study Description

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

The purpose of this study is to develop and implement a treatment that focuses on behaviors to reduce symptom severity and functional impairment in patients with Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type (ADHD-I). The long-term goal of this study is to apply the treatment to larger-scale trials to determine its effectiveness and generalizability.

Condition or disease	Intervention/treatment	Phase
Attention Deficit Disorder With Hyperactivity	Behavioral: Psychosocial (behavioral) Intervention	Not Applicable

Detailed Description:

ADHD-I is a highly prevalent and serious childhood disorder that affects academic and social development. The symptoms of ADHD-I differ from those of the well-studied ADHD Combined Type. Unfortunately, studies of psychosocial interventions for ADHD-I are currently unavailable. Effective treatments for ADHD-I are still needed.

Participants are randomly assigned to receive either a behavioral intervention or treatment as usual for 10 to 12 weeks. The behavioral intervention includes parent and child skill development groups, family meetings, and consultation with the child's teacher to address attention problems and areas of impairment at home and school. Parent and child interviews, teacher and child ratings, and psychoeducational testing are used to assess participants. Participants are assessed post-treatment and at a 2-month follow-up visit.

Study Design

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Interventional (Clinical Trial)
Enrollment :	60 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Primary Purpose:	Treatment
Official Title:	Psychosocial Treatment for ADHD Inattentive Type I
Study Start Date :	September 2002
Actual Study Completion Date :	June 2007

Arms and Interventions

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Outcome Measures

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	7 Years to 11 Years (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

• ADHD, Predominantly Inattentive Type
• Public or private school attendance
• English speaking

Contacts and Locations

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Locations

United States, California
HALP Clinic, Children's Center at Langley Porter, UCSF
San Francisco, California, United States, 94143

Sponsors and Collaborators

University of California, San Francisco

National Institute of Mental Health (NIMH)

More Information

Go to 

Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

ClinicalTrials.gov Identifier:	NCT00071656 History of Changes
Other Study ID Numbers:	R21MH065927 ( U.S. NIH Grant/Contract ); DSIR CT-S
First Posted:	October 30, 2003
Last Update Posted:	August 9, 2013
Last Verified:	August 2013

Additional relevant MeSH terms:

Attention Deficit Disorder with Hyperactivity; Hyperkinesis; Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders	Dyskinesias; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms